Effects of filgotinib on anemia, thrombocytopenia and leukopenia: Results from a phase 3 study in patients with active rheumatoid arthritis and prior inadequate response or intolerance to biological dmards

Category Primary study
ConferenceArthritis and Rheumatology
Year 2019
This article has no abstract
Epistemonikos ID: b557ba14411535e3348644b9bb0250f8062d6a46
First added on: Apr 30, 2026